| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/13/2011 | WO2011004725A1 Method for detection of pathogenic bacteria, and kit for use in the method |
| 01/13/2011 | WO2011004653A1 Nucleic acid extraction kit, nucleic acid extraction method, and nucleic acid extraction apparatus |
| 01/13/2011 | WO2011004517A1 Method for detection of target nucleic acid, and method for testing for colorectal cancer |
| 01/13/2011 | WO2011004361A2 Long-acting coagulation factors and methods of producing same |
| 01/13/2011 | WO2011004192A1 Animal models and therapeutic molecules |
| 01/13/2011 | WO2011004051A1 Gene therapy compositions for preventing and/or treating autoimmune diseases |
| 01/13/2011 | WO2011004011A1 Variants of plasminogen and plasmin |
| 01/13/2011 | WO2011004008A1 Process for preparation of tacrolimus |
| 01/13/2011 | WO2011004005A1 Rock2 and rock3, two new gain-of-function variants of the cytokinin receptors ahk2 and ahk3 |
| 01/13/2011 | WO2011004003A1 Disruption of ckx3 and at least one other ckx gene in a plant or plant cell leads to improved traits |
| 01/13/2011 | WO2011003988A1 A method for inducing extended self-renewal of functionally differentiated somatic cells |
| 01/13/2011 | WO2011003984A1 Means and methods for detecting and identifying a novel bacterium responsible for phytosanitary disorders in plants (zucchini) and novel resistant plants |
| 01/13/2011 | WO2011003968A1 A fungal protease and use thereof |
| 01/13/2011 | WO2011003925A1 Humanised antibodies to toll-like receptor 2 and uses thereof |
| 01/13/2011 | WO2011003901A1 Expression cassettes for endosperm-specific expression in plants |
| 01/13/2011 | WO2011003896A1 Detection and visualization of the cell cycle in living cells |
| 01/13/2011 | WO2011003850A1 Method for providing fertile plants via induction of bbm during transformation |
| 01/13/2011 | WO2011003800A1 Plants having modulated carbon partitioning and a method for making the same |
| 01/13/2011 | WO2011003780A1 Bi-specific digoxigenin binding antibodies |
| 01/13/2011 | WO2011003557A1 A complex of bi-specific antibody and digoxigenin conjugated to a therapeutic or diagnostic agent |
| 01/13/2011 | WO2011003471A1 Method for providing mature transgenic recalcitrant plants via induction of bbm during regeneration |
| 01/13/2011 | WO2011003237A1 Use of two microrna moleculars in lung caner prognosis and medicine preparation |
| 01/13/2011 | WO2011003194A1 Oncolytic viruses and methods for treating neoplastic disorders |
| 01/13/2011 | WO2010135714A3 Methods for modulating adipocyte expression using microrna compositions |
| 01/13/2011 | WO2010134686A3 Soluble myostatin pro-domain recombinant protein having myostatin inhibitory activity and use thereof |
| 01/13/2011 | WO2010133668A3 Eukaryotic host cell comprising an expression enhancer |
| 01/13/2011 | WO2010130771A3 Compositions and methods for inhibiting expression of glucocorticoid receptor (gcr) genes |
| 01/13/2011 | WO2010123982A3 Gene expression signatures associated with resistance to imatinib mesylate |
| 01/13/2011 | WO2010123200A3 Bacteriophage which kills pathogenic enteric bacteria |
| 01/13/2011 | WO2010118337A3 Methods of enhancing yield of active iga protease |
| 01/13/2011 | WO2010107740A3 Treatment of delta-like 1 homolog (dlk1) related diseases by inhibition of natural antisense transcript to dlk1 |
| 01/13/2011 | WO2010107733A3 Treatment of nuclear factor (erythroid-derived 2)-like 2 (nrf2) related diseases by inhibition of natural antisense transcript to nrf2 |
| 01/13/2011 | WO2010105257A3 Generation of mouse induced pluripotent stem cells bytransient expression of a single non- viral polycistronic vector |
| 01/13/2011 | WO2010105020A3 Baculoviruses with enhanced virion production and a method for the production of baculoviruses |
| 01/13/2011 | WO2010104345A3 Apparatus for integrated real-time nucleic acid analysis, and method for detecting a target nucleic acid using same |
| 01/13/2011 | WO2010102277A3 Methods of diagnosing and treating prostate cancer characterized by ndrg1-erg fusion |
| 01/13/2011 | WO2010101947A3 Rapid oligo probes |
| 01/13/2011 | WO2010101903A3 Compositions, methods and kits for preparing plasminogen; and plasmin prepared therefrom |
| 01/13/2011 | WO2010100437A3 Production of protein |
| 01/13/2011 | WO2010099960A3 Assembly activating protein (aap) and its use for the manufacture of parvovirus particles essential consisting of vp3 |
| 01/13/2011 | WO2010099383A3 Compositions and methods for ex vivo hepatic nucleic acid delivery |
| 01/13/2011 | WO2010099169A3 A novel in vitro hiv-1 latency model for screening reactivation agents of hiv-1 |
| 01/13/2011 | WO2010096201A3 Synthesis of ara-2'-o-methyl-nucleosides, corresponding phosphoramidites and oligonucleotides incorporating novel modifications for biological application in therapeutics, diagnostics, g- tetrad forming oligonucleotides and aptamers |
| 01/13/2011 | WO2010095910A3 Polypeptide having function for delaying anthesis or suppressing growth, polynucleotide encoding the same, and use thereof |
| 01/13/2011 | WO2010091441A3 Stable, functional chimeric cellobiohydrolases |
| 01/13/2011 | WO2010075529A9 Heterologous biomass degrading enzyme expression in thermoanaerobacterium saccharolyticum |
| 01/13/2011 | WO2010054348A8 Pathogen-inducible promoters and their use in enhancing the disease resistance of plants |
| 01/13/2011 | WO2010017328A3 Cyclodextrin conjugates for sirna delivery |
| 01/13/2011 | WO2006076628A9 Compositions comprising promoter sequences and methods of use |
| 01/13/2011 | US20110010807 Starch branching enzyme |
| 01/13/2011 | US20110010806 Method of directing the evolution of an organism |
| 01/13/2011 | US20110010805 improved ability to enzymatically degrade lignocellulosic feedstocks; fermentation |
| 01/13/2011 | US20110010804 Genes that increase plant oil and method for using the same |
| 01/13/2011 | US20110010803 Polypeptides, Such As Lipases, Capable Of Altering The Seed Storage Content In Transgenic Plants |
| 01/13/2011 | US20110010802 Antifungal Plant Proteins and Methods of their Use |
| 01/13/2011 | US20110010801 Maize cystatin promoter for pericarp preferred expression |
| 01/13/2011 | US20110010800 Plants with increased yield |
| 01/13/2011 | US20110010799 Floral Transition Genes in Maize and Uses Thereof |
| 01/13/2011 | US20110010798 Drought tolerant plants and related constructs and methods involving gene encoding ferrochelatases |
| 01/13/2011 | US20110010797 Method for changing nitrogen utilization efficiency in plants |
| 01/13/2011 | US20110010796 Water deficit-inducible promoters |
| 01/13/2011 | US20110010795 Ap2 domain transcription factor odp2 (ovule development protein 2) and methods of use |
| 01/13/2011 | US20110010794 Method for improving plant tolerance to environmental stress |
| 01/13/2011 | US20110010792 Plant polynucleotides for improved yield and quality |
| 01/13/2011 | US20110010790 Plants with modified lignin content and methods for production thereof |
| 01/13/2011 | US20110010789 Soybean variety a1016494 |
| 01/13/2011 | US20110010788 Soybean variety a1016174 |
| 01/13/2011 | US20110010787 Soybean variety a1016497 |
| 01/13/2011 | US20110010786 Transgenic animal expressing b cell antigen receptor |
| 01/13/2011 | US20110010784 Insulin-like gene of prawns and uses thereof |
| 01/13/2011 | US20110010783 Method for reprogramming in vitro stem cells and somatic cells into germinal cells |
| 01/13/2011 | US20110010781 Method of Producing a Mouse Suitable for Engraftment, Differentiation and Proliferation of Heterologous Cells, Mouse Produced by This Method and Use of the Mouse |
| 01/13/2011 | US20110009655 Novel atp:citrate lyase genes |
| 01/13/2011 | US20110009611 Clarification of sphingans and compositions thereof |
| 01/13/2011 | US20110009602 Human cd28 specific monoclonal antibodies for antigen-nonspecific activation of t-lymphocytes |
| 01/13/2011 | US20110009598 Method of producing cell extract for cell-free protein synthesis |
| 01/13/2011 | US20110009472 RNAi Probes Targeting Cancer-Related Proteins |
| 01/13/2011 | US20110009471 Oligonucleotide analogues and methods utilizing the same |
| 01/13/2011 | US20110009469 Compositions and methods of treating neoplasia |
| 01/13/2011 | US20110009468 Mirna, sirna and use thereof in therapy |
| 01/13/2011 | US20110009467 Methods to Increase or Decrease Bone Density |
| 01/13/2011 | US20110009329 Method for treating neurodegenerative diseases |
| 01/13/2011 | US20110009316 Proteolysis resistant active vegf |
| 01/13/2011 | US20110009312 Albumin Fusion Proteins |
| 01/13/2011 | US20110009308 Subtilase Variants Having Altered Immunogenicity |
| 01/13/2011 | US20110009291 Methods and compositions for increasing membrane permeability |
| 01/13/2011 | US20110009289 Methods of using an array of pooled probes in genetic analysis |
| 01/13/2011 | US20110009281 Methods for creating and identifying functional rna interference elements |
| 01/13/2011 | US20110009280 Multi-chain eukaryotic display vectors and uses thereof |
| 01/13/2011 | US20110009275 Methods of amplifying and sequencing nucleic acids |
| 01/13/2011 | US20110008913 Tumor suppressor gene |
| 01/13/2011 | US20110008895 Methods and materials for the reproducible generation of high producer cell lines for recombinant proteins |
| 01/13/2011 | US20110008894 Lyophilized plasmid/dna transfection reagent carrier complex |
| 01/13/2011 | US20110008885 Linear double-stranded rna molecule interfering with different target genes |
| 01/13/2011 | US20110008883 Mammalian cell-based immunoglobulin display libraries |
| 01/13/2011 | US20110008882 SPECIFIC GRP78 EXPRESSION-INHIBITION RNAi SEQUENCE, MEDICINE THEREOF AND METHOD THEREOF |
| 01/13/2011 | US20110008870 Fungal protease and use thereof |
| 01/13/2011 | US20110008869 Engineered proteases for affinity purification and processing of fusion proteins |
| 01/13/2011 | US20110008860 Genes encoding key catalyzing mechanisms for ethanol production from syngas fermentation |
| 01/13/2011 | US20110008856 Biological Systems for Manufacture of Polyhydroxyalkanoate Polymers Containing 4-Hydroxyacids |